Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical terbinafine formulation system in laser-treated toenails versus ciclopirox lacquer for onychomycosis
2006-005895-42Phase 3Completed
- Sponsor
- TLT Medical
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of Terbinafine and ciclopirox in onychomycosis (2 arms), sponsored by TLT Medical. Primary endpoint: Complete cure at Week 48. Started Jan 2007; status: completed.
02
Drugs
Terbinafineciclopirox
03
Conditions
onychomycosis
Beyond the preview
Go deeper on 2006-005895-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005895-42.